Logo
Log in
Subscribe
Type 1 Diabetes Weekly

Type 1 Diabetes Weekly

A weekly curated digest of the most significant Type 1 diabetes research, treatments, and innovations, focusing on scientific advancements, medical technologies, and global approaches to care. Each issue delivers concise summaries of cutting-edge studies, emerging therapies, and real-world patient experiences with direct links to explore further.

#52 - 🔌 AID tech works for older adults

May 26, 2026

•

3 min read

#52 - 🔌 AID tech works for older adults

Plus: a CGM that lasts a full year

#51 - 📡 Dexcom G8: What we know so far

May 19, 2026

•

4 min read

#51 - 📡 Dexcom G8: What we know so far

#50 - 💉 GLP-1s meet T1D: hype or hope?

May 12, 2026

•

3 min read

#50 - 💉 GLP-1s meet T1D: hype or hope?

#49 - 🧃 Juicebox's new T1D toolkit

Apr 28, 2026

•

3 min read

#49 - 🧃 Juicebox's new T1D toolkit

Plus: FDA clears Control-IQ+ for pregnancy

#48 - 🔬 Teplizumab's big trial is here

Apr 22, 2026

•

3 min read

#48 - 🔬 Teplizumab's big trial is here

Plus stem cells, implantable CGMs & more

#47 - 🧠 T1D genes are active in your brain

Apr 15, 2026

•

6 min read

#47 - 🧠 T1D genes are active in your brain

Load more

Type 1 Diabetes Weekly

A weekly curated digest of the most significant Type 1 diabetes research, treatments, and innovations, focusing on scientific advancements, medical technologies, and global approaches to care. Each issue delivers concise summaries of cutting-edge studies, emerging therapies, and real-world patient experiences with direct links to explore further.

© 2026 Data Drift Press.
Report abusePrivacy policyTerms of use
beehiivPowered by beehiiv